Evidence map›Paper›PMID 42429823›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Efficacy and outcomes of [

Martin Rust, David Ventura, Clemens Backhaus, Ole Platte, Benjamin Matheja, Michael Schäfers, Martin Bögemann, Lars Stegger, Wolfgang Roll, Kambiz Rahbar

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Martin RustDepartment of Nuclear Medicine, University Hospital Münster, Münster, Germany. martin.rust@ukmuenster.de.ORCID http://orcid.org/0009-0002-8903-1913
David VenturaDepartment of Nuclear Medicine, University Hospital Münster, Münster, Germany.
Clemens BackhausDepartment of Nuclear Medicine, University Hospital Münster, Münster, Germany.
Ole PlatteDepartment of Nuclear Medicine, University Hospital Münster, Münster, Germany.
Benjamin MathejaDepartment of Nuclear Medicine, University Hospital Münster, Münster, Germany.
Michael SchäfersDepartment of Nuclear Medicine, University Hospital Münster, Münster, Germany.
Martin BögemannWest German Cancer Center, Münster, Germany.
Lars SteggerDepartment of Nuclear Medicine, University Hospital Münster, Münster, Germany.
Wolfgang RollDepartment of Nuclear Medicine, University Hospital Münster, Münster, Germany.
Kambiz RahbarDepartment of Nuclear Medicine, University Hospital Münster, Münster, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose[

methodsWe retrospectively analyzed electronic health records of mCRPC patients treated with [

resultsAmong 108 patients, 65 received [

conclusionIn this real-world cohort of ARPI- and taxane-pretreated mCRPC patients, concurrent ARPI use during [

Indexed as

DipeptidesHeterocyclic Compounds, 1-RingLutetiumProstatic Neoplasms, Castration-ResistantReceptors, AndrogenAgedHumansMaleMiddle AgedProstate-Specific AntigenRadioisotopesRetrospective StudiesTreatment OutcomeDipeptidesHeterocyclic Compounds, 1-RingLutetiumLutetium-177lutetium (177Lu) vipivotide tetraxetanProstate-Specific AntigenPSMA-617RadioisotopesReceptors, AndrogenCastration-resistantOverall survivalProstate-specific antigenProstatic neoplasmsRadioligand therapy

Identifiers

PMID42429823
PMCPMC13633381

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.